1. Jiajia R, Xuting J, Jiamei L, Ruohan L, Ya G, Jingjing Z, et al. The global burden of peptic ulcer disease in 204 countries and territories from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. Int J Epidemiol 2022; 51(5): 1666-76. https: //doi.org/10.1093/ije/dyac033 [
DOI:10.1093/ije/dyac033]
2. Sayehmiri K, Abangah GH, Kalvandi GH, Tavan H, Aazami S. Prevalence of peptic ulcer in Iran: Systematic review and meta analysis method. J R Med Sci 2018;23: 8. https: // doi.org/10.4103/jrms.JRMS_1035_16 [
DOI:10.4103/jrms.JRMS_1035_16]
3. Kavitt RT, Lipowska AM, Yeboa AA, Gralnek. IM. Diagnosis and Treatment of Peptic Ulcer Disease. Am J Med 2019;132(4): 447-56. https: //doi.org/10.1016/j.amjmed.2018.12.009 [
DOI:10.1016/j.amjmed.2018.12.009]
4. Milani M, Somi MH, Akbarzadeh A. Prevalence of Hlicobacter pylori BABA2, BABB and OIPA genotypes in dyspeptic patients. Studies in Medical Sciences. 2018;29(4): 255-63. URL: http: //umj.umsu.ac.ir/article-1-3993-fa.html [
Google Scholar]
5. Abbasi F, Sefidgar F. Frequency of Gastric Lesions in Endoscopic Samples in Urmia Imam Khomeini Hospital. Stud Med Sci 2018;29(8): 557-63. URL: http: //umj.umsu.ac.ir/article-1-3316-fa.html [
Google Scholar]
6. Abidkanjo F, Soleimani N, Hosseini S M, Zanotti G. Immunological effects of FLGE2 recombinant in Hlicobacter pylori on TNF-A cytokine oroduction in macrophage cells in vitro. Stud Med Sci 2022;33(1): 45-53. https: //doi.org/10.52547/umj.33.1.45 [
DOI:10.52547/umj.33.1.45]
7. Ciesielska A, Matyjek M, Kwiatkowska K. TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling. Cell Mol Life Sci 2021;78(4): 1233-61. https: //doi.org/10.1007/s00018-020-03656-y [
DOI:10.1007/s00018-020-03656-y]
8. Singh HB, Borbora D. In silico evaluation of the human CD14 gene revealed high-risk single nucleotide polymorphisms and their impact on the innate immune response against microbial pathogens. Peer J 2019;7: e7325. https: //doi.org/10.1016/j.mgene.2018.05.010 [
DOI:10.1016/j.mgene.2018.05.010]
9. Jia X, Wang B, Yao Q, Li Q, Zhang J. Variations in the CD14 gene are associated with autoimmune thyroid diseases in the Chinese population. Front Endocrinol 2019;9(811): 1-11. https: //doi.org/10.3389/fendo.2018.00811. [
DOI:10.3389/fendo.2018.00811]
10. Sharygin D, Koniaris LG, Wells C, Zimmers TA, Hamidi T. Role of CD14 in human disease. Immunology 2023;169(3): 260-70. https: //doi.org/10.1111/imm.13634 [
DOI:10.1111/imm.13634]
11. Wang J, Guo X, Yu S, Song J, Zhang J, Cao Z, et al. Association between CD14 Gene Polymorphisms and Cancer Risk: A Meta-Analysis. Plos One 2014;9(6): e100122. https: //doi.org/10.1371/journal.pone.0100122 [
DOI:10.1371/journal.pone.0100122]
12. Michalkiewicz J, Basa AH, Grzywa R, Czerwionka M, Poplawska A, Mierzwa G, et al. Innate Immunity Components and Cytokines in Gastric Mucosa in Children with Helicobacter pylori Infection. Mediators Inflamm 2015;e176726. [
DOI:10.1155/2015/176726]
14. Frauenlob T, Neuper T, Mehinagic M, Dang H, Boraschi D, Hoeck J. Helicobacter pylori Infection of Primary Human Monocytes Boosts Subsequent Immune Responses to LPS. Fron Immunol 2022;13: e847958 https: //doi.org/10.3389/fimmu.2022.847958 [
DOI:10.3389/fimmu.2022.847958]
15. Périco LL, Tavares M, Silva E, Ohara R, Rodrigues VP, Bueno G, et al. Systematic Analysis of Monoterpenes: Advances and Challenges in the Treatment of Peptic Ulcer Diseases. Biomolecules 2020;10: 265. https: //doi.org/10.3390/biom10020265 [
DOI:10.3390/biom10020265]
16. Sijmons D, Guy AJ, Walduck AK, Ramsland PA. Helicobacter pylori and the Role of Lipopolysaccharide Variation in Innate Immune Evasion. Front Immunol 2022;13: 868225. https: //doi.org/10.3389/fimmu.2022.868225 [
DOI:10.3389/fimmu.2022.868225]
17. Na K, Oh BC, Jung Y. Multifaceted role of CD14 in innate immunity and tissue homeostasis. Cytokine Growth Factor Rev 2023;74: 100-7. https: //doi.org/10.1016/j.cytogfr.2023.08.008 [
DOI:10.1016/j.cytogfr.2023.08.008]
18. Zare Marzouni H, Farid-Hosseini R, Jabari-Azad F, Tavakkol-Afshari J, Tehranian F, et al. CD14 as A Serum Immune Biomarker and Genetic Predisposition Factor for Allergic Rhinitis. Iran J Otorhinolaryngol 2019;.31(1): 1-9. https: //doi.org/10.22038/IJORL.2018.28736.1939 [
PMID]
19. Zhao D, Sun T, Zhang X, Guo Y, Yu D, Yang M, et al. The role of CD14 promoter polymorphisms in gastric cancer associated with Helicobacter pylori infection. Clin Cancer Res 2007;13(8): 2362-8. https: //doi.org/10.1158/1078-0432 [
DOI:10.1158/1078-0432.CCR-06-2612]
20. Gong A, Li XY, Xie YQ, Jia ZD, Li YX, Zou YY, et al. Association between CD14 SNP -159 C/T and gastric cancer: an independent case-control study and an updated meta-analysis. Onco Targets Ther 2016;9(11): 4337-42. https: //doi.org/10.2147/OTT.S95807 [
DOI:10.2147/OTT.S95807]
21. Wang C, Shao J, Zhang R, Sheng X, Dong L, Fang Q, et al. Review Article: The role of CD14 159C/T polymorphism in susceptibility of cancers. Int J Clin Exp Med 2019;12(6): 6551-60. https: //doi.org/5901/IJCEM0077365 [
URL]
22. Triantafyllou K, Kourikou A, Gazouli M, Karamanolis GP, DimitriadisGD. Functional dyspepsia susceptibility is related to CD14,GNB3,MIF, and TRPV1 gene polymorphisms in the Greek population. Neurogastroenterol Motil 2017;29(1): e12913. https: //doi.org/10.1111/nmo.12913 [
DOI:10.1111/nmo.12913]
23. Kim EJ, Chung WC, Lee KM, Paik CN, Kim SB, Oh YS, et al. Helicobacter pylori Infection Enhances Gastric Mucosal Inflammation in Individuals Carrying the 260-T Allele of the CD14 Gene. Gut Liver 2013;7(3): 317-22. https: //doi.org/10.5009/gnl.2013.7.3.317 [
DOI:10.5009/gnl.2013.7.3.317]
24. Moghadampour M, Eskandari Nesab E, Shabani F. Association between CD14-159C/T gene polymorphism and risk of acute brucellosis. Asian Pac J Trop Med 2016; 9(3): 247-51. https: //doi.org/10.1016/j.apjtm.2016.01.036 [
DOI:10.1016/j.apjtm.2016.01.036]
25. Akmali A, Shahrokhabadi K, Dehghani H. Investigating the Relationship between C-159T Polymorphism in CD14 Gene Promoter and Disease Severity in 2019 Corona Virus Patients. J North Khorasan Univ Med Sci 2022;14(4): 23-9. (Persian). https: //doi.org/10.32592/nkums.14.4.23 [
DOI:10.32592/nkums.14.4.23]
26. Roy N, Nadda N, Kumar H, Prasad C, Kumar Jha J, Pandey HC, et al. Pattern recognition receptor CD14 gene polymorphisms in alcohol use disorder patients and its Influence on liver disease susceptibility.Front immunol 2022;13: 975027. https: //doi.org/ 10.3389/fimmu.2022.975027 [
DOI:10.3389/fimmu.2022.975027]
27. Xu M, Wang L, Sun L, Li Z, Zhang H. 159C/T polymorphism of CD14 gene and risk of ischemic stroke: a meta-analysis. Int Med Res 2020; 48(3): 300060519886241. https: //doi.org/ 10.1177/0300060519886241 [
DOI:10.1177/0300060519886241]
28. Wu Q, Xu X, Ren J, Liu S, Liao X, Wu X, et al. Association between the -159C/T polymorphism in the promoter region of the CD14 gene and sepsis: a meta-analysis. BMC Anesthesiol 2017;17(11): 1-11. https: //doi.org/10.2147/NDT.S185313 [
DOI:10.1186/s12871-017-0303-9]
29. Panda AK, Tripathy R, Das BK. CD14 (C-159T) polymorphism is associated with increased susceptibility to SLE and soluble CD14 plasma levels are a novel biomarker of disease activity: a hospital-based case-control study. Lupus 2021;30(2): 219-27. https: //doi.org/10.1177/0961203320972799 [
DOI:10.1177/0961203320972799]